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Abstract 
 Unnatural amino acids (UAAs) contain side chains, or R groups, that are not found in the 
20 canonical amino acids.  These noncanonical groups afford the capability to incorporate 
powerful chemical capabilities in proteins that are ordinarily unavailable with the naturally-
occurring amino acids.  Among the most useful moieties to incorporate into proteins are 
functional groups that can undergo Huisgen [3+2] cycloadditions, or “click,” reactions.  This 
reaction occurs between azides and alkynes, and its mild conditions and high regioselectivity and 
reactivity make it an ideal process for bioconjugation.  Photoreactivity is another useful 
characteristic that can be conferred to UAAs.  Photolabile caging groups can inhibit the function 
of a protein until brief irradiation with UV light induces an intramolecular rearrangement and its 
displacement, reestablishing normal function.  In this thesis, we propose a synthesis to 
incorporate both of these moieties into a single UAA.  
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Background 
 Twenty canonical amino acids comprise the core of all proteins in living organisms.
1
  An 
enormous diversity in both structure and function is achieved across the expansive proteome 
despite a relatively miniscule pool of building blocks.  Individual amino acids are polymerized to 
proteins via a dehydration reaction of the amine group of one amino acid with the carboxylic 
acid group of another to form an amide bond, also known as a peptide bond.  The difference 
between each of the amino acids is the side chain, or R group.  These groups contain a range of 
chemical functionalities including nonpolar substituents, such as aromatic rings and alkyl chains, 
polar substituents, such as hydroxyl and amine-containing moieties, as well as basic and acidic 
substituents (Fig 1). 
 The sequence of amino acids dictates the protein’s overall structure, as the protein adopts 
a conformation that minimizes the Gibbs free energy.
1
  Non-covalent interactions between side 
chains and other interactions involving the peptide backbone drive the formation of secondary 
structure of the protein.  The most common of these structures, α-helices and β-sheets, form from 
hydrogen bonding between a lone pair on the peptide carbonyl and the amide hydrogen.  The 
amino acids that comprise α-helices tend to contain straight-chain R groups, such as methionine 
and alanine, whereas β-sheets form with bulky amino acids like tryptophan or phenylalanine.1  
Not all of the protein adopts a secondary structure, however, and instead forms the “irregular 
structure.”   
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Figure 1: List and structures of the 20 canonical amino acids  
http://www.epicnutritiontoday.com/wp-content/uploads/2012/01/amino-acid-table.gif 
 
Secondary and irregular structures are entropically driven to fold into the tertiary 
structure such that hydrophobic-hydrophilic interactions are minimized.
1
  For most proteins, the 
environment is predominately aqueous, so the nonpolar amino acids are sequestered to the 
interior of the proteins.  Approximately 25% of all proteins are bound to the cell membrane,
1
 
resulting in these proteins positioning hydrophobic side chains to the exterior surface as a 
mechanism to interact with the nonpolar aliphatic chains of the phospholipids.  These proteins 
4 
 
also have regions that are not exposed to plasma membrane, and therefore can have polar amino 
acids exposed on the surface to interact with water. 
Proteins are products of gene expression.
1
  In this process, DNA is transcribed to 
messenger RNA (mRNA) which provides the template for the amino acids to be linked together 
to form a polypeptide.  The template is read in groups of three nucleotides called codons, each of 
which corresponds to either an amino acid or for a translational stop.  Codons are translated by 
transfer RNAs (tRNAs), which are molecules with two important functions.  Firstly, tRNAs 
contain an anticodon, which is the complement to a particular codon.  The second important 
function of the tRNA is that it binds a specific amino acid.  Amino acids are covalently bound, or 
charged, to a tRNA by an aminoacyl-tRNA synthase (aaRS).  Each amino acid has one 
corresponding aaRS, even though in some cases there are degenerate codons that encode the 
same amino acid since there are 64 unique codons, but only 20 amino acids (Table 1).   
 
Table 1:  Codons and their associated amino acids 
http://www.biogem.org/codon.jpg 
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Translation of proteins is catalyzed on the ribosome, a large two-unit complex of both 
ribosomal RNA (rRNA) as well as protein.
1
  There are three main sites for protein synthesis in 
the ribosome:  the exit, peptidyl, and aminoacyl sites.  These are commonly abbreviated as the E, 
P, and A sites.  As the mRNA is processed through the ribosome, charged tRNAs enter the 
complex and form a complementary hydrogen bond to the template mRNA in the A site.  The 
ribosome then catalyzes the nucleophilic attack of the A amino acid’s amine to the carboxylic 
acid end of the amino acid in the P site.  The condensation reaction dissociates the peptide from 
the P site tRNA to the A site, growing the peptide chain by one amino acid residue.  Immediately 
following the bond formation, the P site tRNA moves to the E site, the A tRNA moves to the P 
site, and a new charged tRNA can enter the vacant A site.  The discharged E site tRNA is ejected 
every time a peptidyl transfer occurs, upon which time it is almost immediately recharged with 
another amino acid.  Translation is terminated when a stop codon on the mRNA reaches the A 
site and a release factor binds to it, causing the dissociation of the ribosomal subunits (Fig 2). 
A common technique in biology to identify the function of a biological component is to 
determine the consequences of its elimination or alteration from the system.  Oftentimes, if a 
protein is removed the resulting consequence will elucidate the function of the protein.  Instead 
of completely removing a protein, another technique that has surfaced in recent years is the 
utilization of unnatural amino acids (UAAs) to modify the function of a protein.  UAAs defy the 
limit nature has placed on biology by expanding the chemical functionality accessible to proteins 
beyond the 20 canonical amino acids.  The ability to introduce novel side chains containing such 
functionalities as metals, alkynes, fluorophores, and others, allows for new methods to study 
proteins.
2
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Figure 2: Diagram of the initiation, elongation, and termination steps of translation 
http://biology.unm.edu/ccouncil/Biology_124/Images/RNAtranslation.jpeg 
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The first challenge to overcome is to charge tRNA molecules with UAAs.  Nature 
produces remarkably few errors in charging the canonical amino acids to their corresponding 
tRNAs.  As such, a solution is to introduce both orthogonal tRNAs and a corresponding aaRS.
3
  
Orthogonality of these components is achieved by introducing them from an exogenous source, 
such as Methanococcus jannaschii.
3
  The difference in species source prevents cross-reactivity 
with the naturally-encoded aaRSs and tRNAs in E. coli. 
The second major challenge is the development of an aaRS than can recognize and 
charge a UAA to the tRNA.  UAAs can contain unique structures that are unfamiliar to natural 
aaRS proteins, so directed evolution must be performed to develop an aaRS.
4
  A useful aspect to 
evolving an aaRS is the ability to modulate its specificity.  Natural aaRSs have evolved to be 
highly selective to a single amino acid, and are able to discriminate features as minute as the 
single methylene difference between glutamate and aspartate.  Due to the exogenous nature of 
the UAA, there are fewer selective pressures in the development of unnatural aaRSs, leading to 
promiscuity in the UAAs it might recognize.
5
  This modulation allows related UAAs to be 
aminoacylated to a tRNA by the same aaRS.   
UAAs can be incorporated into proteins in E. coli at site-specific locations by taking 
advantage of rarely used stop codons.
6
  There are three stop codons found in nature, and often 
codon bias towards one of the three exists within an organism’s genome.  In E. coli, the UAG 
stop codon is rarely used.  Since this codon is present in few genes, there is a correspondingly 
low concentration of release factors that bind this sequence to terminate translation.  These 
conditions allow for minimal competition for the orthogonal tRNAs that have been engineered to 
contain the complementary anticodon to the UAG codon (Fig. 3).  Introducing engineered 
plasmids that contain genes encoding an orthogonal aaRS and its cognate tRNA, antibiotic 
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resistance, an exogenous protein, and other sequences such as promoters to bacteria facilitates 
the incorporation of UAAs into proteins.
4,6
 
 
Figure 3: Illustration of  UAA incorporation
7
 
 
The selection process for developing aaRSs is twofold (Fig. 4).  First, a positive selection 
is performed by transforming cells with a plasmid encoding an aaRS as well as a mutated gene 
encoding chloramphenicol acetyltransferase
7
 (CAT) with a TAG codon, an enzyme that 
eliminates the antibiotic properties of chloramphenicol by catalyzing its acetylation.  The 
mutation introduces the codon that is complementary to the orthogonal UAA tRNA.  The cells 
are grown in the presence of the chloramphenicol, so only the cells that possess an aaRS that can 
charge an amino acid to the tRNA will produce CAT and survive.  The aaRS has been mutated at 
the tRNA binding site to recognize the anticodon AUC as well as at the amino acid binding site 
to provide the possibility for UAA recognition.  The mutants that survive this selection are then 
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subject to negative selection.  In this process, the cells are transformed with the same aaRS as 
well as a plasmid encoding a mutated barnase gene.
7
  Barnase is a ribonuclease that is toxic to 
cells if expressed.  The cells are grown in the absence of UAAs to select against aaRSs that 
aminoacylate natural amino acids, since barnase will only be expressed if the aaRS can read 
through the TAG codon.  The selection process is repeated multiple times to ensure that the aaRS 
is evolved to truly recognize the desired UAA.
7
 
 
Figure 4: Scheme for aaRS evolution
7
 
 
One of the simplest ways to test for a UAA’s incorporation is to express it in green 
fluorescent protein (GFP), a well characterized reporter protein (Fig. 5) that was discovered in 
jellyfish and emits green light upon irradiation with UV light.
1
  The UV activity makes this 
protein quite easy to find in cells and tissues, so it is often used as a fusion tag to other proteins 
of interest in other fields of research.  The complementary DNA from which the protein is 
translated has been sequenced and the protein itself can be expressed under simple conditions, 
10 
 
making it highly attractive for use in basic research.
8
  The protein’s DNA can be altered to 
contain a nonsense codon anywhere a UAA is desired to be encoded.  Since the two main 
outcomes of a UAG codon in an mRNA are UAA incorporation and translational termination, 
presence of GFP indicates a successful expression with the UAA.  Translation has also been 
shown to proceed through the less-used stop codons in cells in the absence of UAAs, so the 
presence of GFP must be analyzed to ensure that it is not the product of this background 
expression.  
 
Figure 5: GFP structure; within the β-barrel is a unique fluorophore that confers its spectroscopic properties 
https://www.pblassaysci.com/sites/pblassaysci/files/images/Antibody%20structure.jpg 
 
Click reactions in a biological context 
The azide-alkyne cycloaddition, commonly referred to as the “click” reaction, was first 
developed by Huisgen in the 1960s under thermal conditions to produce a mixture of 1,4- and 
1,5-triazoles.
9
  It was not until 2002 when Sharpless discovered that the use of a Cu(I) catalyst 
could afford 91% selectivity for the 1,4-substituted product under mild conditions (Fig. 6).
9
  He 
noted that the reaction was robust to many organic synthesis conditions, including in the 
presence of water and O2, and was tolerant of many functional groups.  For these reasons, along 
11 
 
with the fact that alkynes and azides are virtually nonexistent in biology, this reaction has 
become a prominent tool in the field of bioconjugation.
10
  
Common examples of bioconjugates are various probes that allow for molecular 
imaging.
10
  These chromophores can be clicked to a number of biomolecules that are engineered 
to contain either an azide or alkyne functionality.  For example, this technology has been used in 
mice for positron emission tomography (PET), a powerful medical imaging technique.
11
  In one 
such experiment, researchers were able to engineer the peptide A20FMDV2 which selectively 
binds integrin αvβ3, a protein that is present in abnormally higher concentrations in tumor cells.  
The peptide was modified by the addition of an azide to the N-terminus, which was reacted with 
an alkyne bearing three positron emitting isotopes.  Excellent spatial and temporal resolution was 
achieved through this process.
11
 
 
 
Figure 6:  Mechanism of Cu(I) catalyzed click reaction
8
 
 
Another advantage of the use of clickable UAAs is the ability to conjugate different 
labels to a protein in fluorescence resonance energy transfer (FRET) studies.
12
  Click conditions 
12 
 
are facile and do not interfere with cysteine-labeling conditions.  The thiol group of cysteine is 
commonly reacted irreversibly with maleimides in protein chemistry (Fig. 7).
13
  This is because 
cysteine residues are present in many proteins, albeit in low numbers, and the thiol group makes 
it the most nucleophilic amino acid.  The low abundance of cysteine makes its conjugation to 
fluorophores or other molecules a highly specific process.  When both cysteine-maleimide and 
azide-alkyne conjugation can be achieved in the same protein, conditions for FRET experiments 
can be prepared with ease.
12
  The use of clickable UAAs in proteins allows for high specificity in 
bioconjugation, providing well-defined conjugates.  Bioconjugation with any of the canonical 
amino acids is imprecise in both location and number of conjugates formed, since there are 
multiple residues that can react. 
 
Figure 7: General mechanism of cysteine-maleimide conjugation 
 
Photocaging biological systems 
Caging biomolecules, such as proteins, with a photolabile protecting group can inhibit the 
function of the protein until it is decaged by brief irradiation with UV light.   Nitro groups 
readily undergo photochemical reactions by promoting radical formation.  When 2-nitrobenzyl 
groups are subject to UV light, one of the oxygen atoms will migrate to the neighboring alkyl 
groups, leaving a nitroso group (Fig. 8).
14
  If this moiety was an R group of an amino acid chain, 
then the nitroso could further react with the amide nitrogen to form a 6-membered ring.
15
  After 
13 
 
rearrangement, hydrolysis releases the newly formed ring and the peptide is cleaved in two (Fig. 
9).
15 
 
Figure 8: General decaging mechanism
14 
 
 
Figure 9: Mechanism of photoinitiated peptide cleavage
12
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The inhibition can occur by the incorporation of a caged UAA, such as ONBY (Fig. 10), 
into the active site of a protein.  This method has been performed on the RNA polymerase of 
bacteriophage T7 (T7RNAP).
16
  T7RNAP was mutated at Tyr639, a necessary component of the 
active site, with ONBY.  Upon irradiation with UV light, the ortho-nitrobenzyl group was 
cleaved, activating the protein by revealing a tyrosine residue.
16
 
 
Figure 10: (O-nitrobenzyl)tyrosine (ONBY) 
  
The goal of this study was to synthesize novel unnatural amino acids (UAAs) bearing 
substituents that afford unique chemical capabilities in biological systems upon incorporation 
into proteins.  UAA 1 (Fig. 11) is a tyrosine derivative with two notable functional groups- an 
ortho-nitrobenzyl group and a para-propargyl group.  The propargyl group provides a handle on 
which to perform “click” reactions with azide-containing substrates.  The ortho-nitrobenzyl 
substituent affords the ability to cleave the peptide backbone, freeing the UAA and its conjugate 
upon UV irradiation. 
 
Figure 11: UAA 1 
15 
 
 Other UAAs were synthesized, most of which were propargyl-modified tyrosine 
derivatives like 1.  UAA 10 (Fig. 12) was made possessing a propargyl group at the para 
position.  Another UAA was attempted to be prepared with an ethylene linker between the 
phenolic oxygen of the tyrosine and a propargyl ether (Fig. 13).  The latter UAA was intended to 
be one of several UAAs with linkers of varying length to either azides or alkynes in order to 
distance the reactive moiety from the core of the protein, but the products of early synthetic steps 
were not recovered. 
 
Figure 12: UAA 10 
 
 
Figure 13: Proposed UAA with an ethylene-extended propargyl group 
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Experimental 
General. Solvents and reagents were obtained from either Sigma-Aldrich or Fisher Scientific 
and used without further purification, unless noted. Reactions were conducted under ambient 
atmosphere with un-distilled solvents, unless otherwise noted. Microwave reactions were 
conducted in a CEM Discover microwave reactor.  NMR data was acquired on a Varian Gemini 
400 MHz. Escherichia coli BL21(DE3) cell lines were obtained from Novagen. The various 
plasmids utilized during the transformations were obtained through either collaborators or 
Novagen.  Microtiter plate data was acquired on a Wallac Victor
2
 1420 multilabel counter. 
 
Synthesis of a Clickable Photoreactive Unnatural Amino Acid 
(3-methoxy-4-(prop-2-yn-1-yloxy)benzaldehyde), 2:  Vanillin (3 g, 20 mmol, 1 eq) was stirred 
with K2CO3 (8.29 g, 60 mmol, 3 eq) for 5 minutes in DMF (15 mL).  The mixture was cooled to 
0 ˚C in an ice bath, followed by slow addition of propargyl bromide (3.28 mL, 3.56 g, 30 mmol, 
1.5 eq).  The reaction was warmed to room temperature and stirred for 16 hours.  The reaction 
was quenched by the addition of H2O (30 mL) and extracted with EtOAc (3x40 mL) and back 
extracted with brine (3x80 mL).  The organic layer was dried with Mg2SO4, filtered, and 
concentrated by rotatory evaporation.  The resulting oil was purified by flash chromatography 
(5:1 Hexanes: EtOAc, then 3:1 Hexanes: EtOAc) yielding a white solid (2.88 g, 15 mmol, 77% 
yield).
17 
 
 (5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)methanol, 3:  2 (0.244 g, 1.3 mmol, 1 eq) 
was wrapped in foil and placed in an ice bath at 0 ˚C.  70% HNO3 (5mL, excess) was added 
slowly to the reaction, and it stirred for 10 minutes.  The reaction was warmed to room 
17 
 
temperature and stirred an additional hour.  The contents of the reaction were added to 0 ˚C H2O 
(70 mL) and collected by vacuum filtration.  Ice water (3x10 mL) was used to rinse the reaction 
vessel and collect the residual product.  The product was extracted from the filter paper by 
rinsing with a small volume of DCM, which was removed by rotatory evaporation.  The resulting 
bright yellow solid (0.220 g, 1.0 mmol, 77% yield) required no further purification. 
1
H NMR (400MHz; CDCl3): ∂ 10.45 (s, 1H), 7.79 (s, 1H), 7.43 (s, 1H), 4.90 (s, 2H), 4.02 (s, 
3H), 2.62 (s, 1H) 
13
C NMR (400MHz; CDCl3): ∂ 187.93, 153.94, 146.68, 140.22, 126.64, 110.48, 109.62, 78.00, 
76.56, 57.45, 57.02 
 
(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)methanol, 4:  3 (28 mg, 0.119 mmol, 1 eq) 
was dissolved in 1 mL EtOH, wrapped in foil, and placed in an ice bath.  NaBH4 (14 mg, 0.357 
mmol, 3 eq) was dissolved in 1M NaOH (1 mL).  The NaBH4 solution was then added to the 
solution of 3 dropwise over a period of 2 minutes.  Once all the reducing agent was added, it was 
removed from the ice bath and stirred at room temperature for 45 minutes.  The reaction was 
quenched by neutralizing the reaction with 0.6M HCl and extracted in DCM (3x15 mL).  The 
organic layer was dried with Mg2SO4, filtered, and concentrated by rotatory evaporation.  The 
resulting pale yellow solid (20 mg, 0.084 mmol, 71% yield) required no further purification.   
 
1
H NMR (400MHz; CDCl3): ∂ 7.89 (s, 1H), 7.22 (s, 1H), 4.98 (s, 2H), 4.84 (s, 2H), 4.01 (s, 3H), 
2.58 (s, 1H), 1.56 (s, 1H) 
13
C NMR (400MHz; CDCl3): ∂ 153.94, 146.68, 140.22, 126.64, 111.09, 78.00, 76.56, 63.02, 
57.26, 29.94 
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1-(bromomethyl)-5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzene, 5: 4 (20 mg, 0.084 
mmol, 1 eq) was dissolved in DCM (<1 mL) and wrapped in foil.  PBr3 (8 μL, 0.023 g, 0.084 
mmol, 1eq) was added to the reaction vessel and stirred for 2 hours.  The reaction was quenched 
by the addition of H2O (5 mL) and extracted in DCM (3x15 mL).  The organic layer was dried 
with Mg2SO4, filtered, and concentrated by rotatory evaporation.  The resulting oil was purified 
by flash chromatography (3:1 hexanes: EtOAc), yielding a yellow solid (20 mg, 0.067 mmol, 
79% yield). 
1
H NMR (400MHz; CDCl3): ∂ 7.85 (s, 1H), 6.98 (s, 1H), 4.87 (s, 2H), 4.84 (s, 2H), 4.01 (s, 3H), 
2.60 (s, 1H),  
13
C NMR (400MHz; CDCl3): ∂ 153.94, 146.68, 140.22, 128.68, 114.29, 111.26, 57.25, 56.80, 
29.94  
 
Diethyl 2-acetamido-2-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzyl)malonate, 6:  
Diethyl acetamidomalonate (5 mg, 0.025 mmol, 1.5 eq) and Cs2CO3 (8 mg, 0.025 mmol, 1.5 eq) 
were stirred in CH3CN (1 mL) for 5 minutes.  5 (5 mg, 0.017 mmol, 1 eq) was dissolved in 
CH3CN (2 mL) and added to the diethyl acetamidomalonate solution in a microwave vial.  The 
reaction was subjected to microwave irradiation (130 ˚C, 0-300 W, 10 minutes) and quenched by 
the addition of H2O (5 mL).  The reaction was extracted in DCM (4x15 mL) and back extracted 
with brine (4x80 mL), dried with Mg2SO4, filtered, and concentrated by rotatory evaporation.  
The resulting oil was purified by flash chromatography (1:1 hexanes: EtOAc), yielding a peach-
colored solid (9 mg, 0.020, 80% yield). 
1
H NMR (400MHz; CDCl3): ∂ 7.69 (s, 1H), 6.76 (s, 1H), 6.52 (s, 1H), 4.80 (s, 2H), 4.33-4.13 
(m, 4H), 4.10 (s, 3H), 3.90 (s, 2H), 2.59 (s, 1H), 1.94 (s, 3H), 1.29 (t, J = 7.2, 6H) 
19 
 
13
C NMR (400MHz; CDCl3): ∂ 169.67, 167.83, 152.89, 145.75, 142.08, 126.11, 116.03, 115.95, 
78.00, 76.56, 66.09, 63.05, 57.05, 56.52, 35.17, 14.02, 14.00 
 
1-carboxy-2-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)ethan-1-aminium, 1:  7 (14 
mg, 0.032 mmol, 1 eq) was stirred with 6M HCl (2 mL, excess) under microwave irradiation (90 
˚C, 10 minutes).  The reaction was concentrated by rotatory evaporation, yielding a solid (9 mg, 
0.030 mmol, 95% yield). 
1
H NMR (400MHz; CDCl3): ∂ 7.70 (s, 1H), 6.83 (s, 2H), 6.74 (s, 1H), 4.81 (s, 2H), 4.08 (s, 1H), 
3.91 (s, 3H), 2.19 (s, 2H) 
 
Cycloaddition of 6 with Sodium Azide 
6 (0.010 g, 0.023 mmol, 1 eq), NaN3 (0.002 g, 0.031 mmol, 1.3 eq), 1M CuSO4 (7 μL), and 1M 
sodium ascorbate (17 μL) were wrapped in foil and stirred in DMSO (2 mL) and H2O (2 mL) for 
24 hours at room temperature.  The reaction was extracted in DCM (3x10 mL), dried with 
Mg2SO4, filtered, and concentrated by rotatory evaporation.  The resulting oil was purified by 
flash chromatography (1:1 hexanes: EtOAc), yielding  a faintly yellow solid (0.010 g, 0.021 
mmol, 67% yield). 
 
Synthesis of Other Unnatural Amino Acids 
Synthesis of p-propargyloxyphenylalanine (pPrF) 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoate, 8:  
Methyl (tert-butoxycarbonyl)-L-tyrosine (0.500 g, 1.693 mmol, 1 eq) was stirred with Cs2CO3 
(0.896 g, 2.539 mmol, 1.5 eq) and KI (catalytic amount) in DMF (5 mL) for 15 minutes.  
20 
 
Propargyl bromide (0.736 mL, 0.8056 g, 6.772 mmol, 4 eq) was added slowly.  The reaction was 
allowed to proceed at 60 ˚C for 16 hours.  The reaction was then quenched by the addition of 
H2O (5 mL), extracted in DCM (4x15 mL) and back extracted with brine (4x120 mL).  The 
organic layer was dried with Mg2SO4, filtered, and concentrated by rotatory evaporation.  The 
resulting oil was purified by flash chromatography (3:1 hexanes: EtOAc), yielding a white solid 
(0.394 g, 1.182 mmol, 70% yield).
18 
 
(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid, 9:  8 
(0.394 g, 1.182 mmol, 1 eq) was placed in an ice bath and stirred with 1M NaOH and dioxane (1 
mL ea) for five minutes.  The reaction was warmed to room temperature and stirred for 1 hour.  
The reaction was concentrated by rotatory evaporation, and the remaining aqueous layer was 
acidified (pH 4) with 1M HCl and extracted with EtOAc (3x10 mL).  The organic layer was 
dried with Mg2SO4, filtered, and concentrated by rotatory evaporation, yielding a white solid 
(0.117 g, 0.366 mmol, 31% yield).
18 
 
(S)-2-amino-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid, 10:  9 (0.117 g, 0.366 mmol, 1 
eq) was stirred with 1% TFA (2 mL) on ice for 5 minutes.  The reaction was warmed to room 
temperature and stirred for an additional 1 hour.  The solution was concentrated by rotatory 
evaporation, yielding a white solid (0.080 g, 0.366 mmol, 100% yield).
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Synthesis of a Clickable Unnatural Amino Acid with an Extended Linker 
Methyl (S)-3-(4-(2-bromoethoxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 11: 
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Methyl (tert-butoxycarbonyl)-L-tyrosine (0.122 g, 0.413 mmol, 1 eq) was dissolved in DMF (3 
mL) and stirred with Cs2CO3 (0.219 g, 0.620 mmol, 1.5 eq) for 15 minutes.  Dibromoethane (71 
μL, 0.154 g, 0.826 mmol, 2 eq) and KI (catalytic amount) were added to the solution and stirred 
for 24 hours at 60 ˚C.  The reaction was quenched by the addition of H2O (10 mL) and extracted 
in DCM (3x15 mL).  The organic layer was dried with Mg2SO4, filtered, and concentrated by 
rotatory evaporation, yielding a white solid that was not the desired product, 11. 
 
3-(2-bromoethoxy)prop-1-yne, 13:  Propargyl alcohol (23 μL, 0.022g, 0.0387 mmol, 1 eq) was 
stirred with t-BuOK (0.192 g, 1.16 mmol, 3 eq) for 15 minutes in DMF (5 mL).  1,2-
dibromoethane (100 μL, 0.218 g, 1.16 mmol, 3 eq) was added to the reaction and stirred for 24 
hours at room temperature.  The reaction was quenched by the addition of H2O (10 mL) and 
extracted in DCM (3x15 mL).  The organic layer was dried with Mg2SO4, filtered, and 
concentrated by rotatory evaporation, yielding a white solid that was not the desired product, 13. 
 
Synthesis of a Malonate-Derived Unnatural Amino Acid 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-iodophenyl)propanoate, 14:  (S)-2-((tert-
butoxycarbonyl)amino)-3-(4-iodophenyl)propanoic acid (0.100g, 0.256 mmol, 1 eq) was stirred 
with NaHCO3 (0.060 g, 0.767 mmol, 3 eq) in DMF (2 mL) for 10 minutes.  CH3I (14 μL, 0.0319 
g, 0.282 mmol, 1.1 eq) was added to the solution and stirred at 60 ˚C for 48 hours.  The reaction 
was quenched by the addition of H2O (10 mL) and extracted in EtOAc (4x10 mL) and back 
extracted with brine (4x100 mL).  The organic layer was dried with Mg2SO4, filtered, and 
concentrated by rotatory evaporation.  The resulting oil was purified by flash chromatography 
(1:1 hexanes:EtOAc), yielding a white solid (0.070 g, 0.172 mmol, 67% yield).
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Diethyl (S)-2-(4-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)phenyl)malonate, 
15:  14 (0.010 g, 2.468 mmol, 1 eq) was stirred with diethyl malonate (5 μL, 0.005 g, 2.96 mmol, 
1.2 eq), CuI (0.001 g, 0.617 mmol, 0.25 eq), L-proline (0.001 g, 0.987 mmol, 0.4 eq), and 
Cs2CO3 (0.032 g, 9.871 mmol, 4 eq) in DMSO (1.5 mL) under argon (1 atm) for 16 hours at 40 
˚C.  The reaction was quenched by the addition of H2O (5 mL), extracted in EtOAc (3x5 mL) 
and back extracted with brine (3x50 mL).  The organic layer was dried with Mg2SO4, filtered, 
and concentrated by rotatory evaporation; however, the desired product, 15, was not recovered. 
 
Assessing the Expression of GFP by the Insertion of UAA1  
A pET-GFPTAG151 plasmid and one of seven plasmids (pEVOL-ONBY, pEVOL-pPrF, 
pEVOL-Ac32, pEVOL-CN3265, pEVOL-pAzoF, pEVOL-Bipy, pEVOL-Ambrx; 0.5 µL each) 
were each transformed to competent BL21(DE3) cells (50 µL; Novagen).  The cells were 
transformed by electroporation (1.8 V, 1s), then recovered in 2xYT media (200 µL) at 37 ˚C for 
1 h.  After plating 75 µL on LB agar containing ampicillin (50 µg/mL) and chloramphenicol (50 
µg/mL), the cells were incubated overnight.  A single colony from each plate was then used to 
inoculate 2xYT containing ampicillin (50 g/mL) and chloramphenicol (50 g/mL) (4 mL). 
After overnight incubation at 37 ˚C, the starter cultures (500 µL) were used to inoculate 2xYT 
media containing ampicillin and chloramphenicol (10 mL ea.).  Each starter culture was used to 
inoculate two expression cultures.  These expression cultures were incubated with shaking at 37 
˚C until the OD600 reached 0.78.  At this point, the expression cultures were induced with 1M 
IPTG (10 L) and 20% arabinose (10 µL).  One of each of the pairs of expression cultures was 
supplemented with 1 (100 µL, 100 mM).  The cultures were then grown for 16 hours at 30˚C. 
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Both expression cultures were pelleted at 5000 rpm for 10 minutes, and then frozen at -80 ˚C for 
24 hours. The cell pellets were resuspended in Bug Buster (500 µL; Novagen) supplemented 
with lysozyme and incubated at room temperature for 20 minutes to lyse the cells.  The cell 
lysate (100 µL) was assessed for fluorescence on a microtiter plate (Table 2). 
 1 2 3 4 5 6 7 8 9 10 11 12 
A ONBY +   ONBY -     pPrF +   pPrF -         
B                         
C Ac32 +   Ac32 -     Bipy +   Bipy -         
D                         
E pAzoF +   pAzoF -     Ambrx +   Ambrx -         
F                         
G CN3265 +   CN3265 -                   
H                         
Table 2: Well coordinates of expression products of different aaRSs with and without UAA supplementation 
 
Expression of GFP by the Insertion of UAA1  
A pEVOL-Bipy plasmid and one of four plasmids (pET-GFPTAG3, pET-GFPTAG133, pET-
GFPTAG151, pET-GFPWALDOTAG151; 0.5 µL each) were added to competent BL21(DE3) 
cells (50 µL; Novagen) and transformed, inoculated, and induced as previously described.  The 
cell lysate was centrifuged at 13,000rpm for 10 minutes.  The supernatant was then added to the 
QIAGEN Ni-NTA Spin Column, and the resulting proteins were purified according to the 
manufacturer’s protocols.  Native PAGE (10%) was performed on each of the native GFP 
mutants.  The gel was subject to UV irradiation to visualize the fluorescent bands and stained 
with Coomassie Blue to visualize all protein bands. 
 
GFP Click Reaction 
The GFP mutants (30 µL), N3-PEG (1 µL), CuSO4 (5 µL, 1 mM), TCEP (4 µL, 2mM), and 
TBTA (1 µL, 5 mM) were wrapped in foil and agitated at 190 rpm for 48 hours.  The reaction 
was assessed by native PAGE. 
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Results and Discussion  
Synthesis of Unnatural Amino Acids 
The synthesis of 1 proceeded according to the planned route (Fig. 14) with minor 
alterations to conditions for most steps, but the syntheses of 4 and 6 required more substantial 
changes.  After optimization of the synthesis twice with small amounts of vanillin (0.75 g), a 
large scale synthesis was attempted using 3 g of vanillin starting material to obtain significant 
quantities of the desired unnatural amino acid. 
 
 
Figure 14: Synthetic scheme for UAA 1 
 
The initial reaction of the synthesis involved propargylation of vanillin (2).  This 
nucleophilic substitution reaction generated a nucleophilic phenoxide which reacted with the 
25 
 
electrophilic propargyl bromide.  Overall the reaction proceeded to near completion and required 
little optimization.  Following an extraction and purification by column chromatography, 2 was 
obtained in 77% yield.  The reaction was performed in DMF, which was not dried at the time of 
utilization.  The yield could likely be improved by the use of anhydrous solvent. 
The propargylated vanillin (2) was next reacted with nitric acid to install a nitro group, 
effectively generating the photoreactive moiety.  The reaction proceeds by electrophilic aromatic 
substitution (Fig. 15).  The electrophilic NO2
+
 cation is generated by acid-catalyzed loss of H2O.  
The nucleophilic aromatic ring of 2 reacts with the electrophile, and a phenyl proton is abstracted 
by water to reestablish aromaticity.  This step of the synthesis proceeded to completion at small 
scales, but proved to be somewhat problematic upon scaling up the reaction conditions.  
Primarily, the lack of complete nitration was especially challenging.  This incompleteness was 
not realized until the following step where the aldehyde was reduced to an alcohol when an 
NMR spectroscopic analysis on the crude product of 4 was performed.  This was remedied by 
resubmitting the non-nitrated alcohol to the same nitration conditions, which not only installed 
the nitro group to the correct position, but also oxidized the alcohol to yield 3 (Fig. 16).   
 
 
Figure 15: Mechanism of nitration 
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Figure 16: Resubmission to nitration conditions 
 
Relatively significant difficulties arose with the reduction of 3 to 4.  This reduction 
occurs by the attack of a hydride ion at the electrophilic aldehyde carbon, generating a 
tetrahedral alkoxide intermediate.  Following acid workup, extraction, and column 
chromatography, 4 is recovered.  In early attempts, the reduction was performed by adding 
NaBH4 to the solution of 3 in EtOH at neutral pH.  The yields were not optimal (3, 0.220 g, 1.5 
eq NaBH4  4, 0.083 g, 37%), but there was enough 4 retrieved to continue with the synthesis.  
The residual starting material recovered and subjected to the reaction conditions again in similar 
yields.  It was thought that the NaBH4 was rendered less potent as a result of reacting with 
atmospheric water, so it was used in greater excess with longer reaction times, and different 
sources of reducing agent were utilized in attempts to drive the reaction to completion.  It was 
ultimately realized that the hydride ions were most likely reacting with the protons on ethanol.  
Consequently, the reaction was prepared in 1M NaOH and the reduction was much more 
successful, nearly doubling the yield from 37% to 71%. 
 The bromination of 4 to 5 occurs by an activated nucleophilic substitution reaction.  First, 
the nucleophilic alcohol reacts with PBr3, displacing a Br
-
 ion (Fig. 17).  The resulting 
phosphorus ester is a good leaving group, and the Br
-
 ion reacts via an SN2 manner to form a C-
Br bond.  The phosphonic dibromide is a better leaving group than Br
-
, so equilibrium favors the 
brominated product.   
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Figure 17: Mechanism of bromination of the primary alcohol 
 
The reaction of 5 to 6 required the modification of conditions.  This step of the synthesis 
tended to be performed and was followed by periods of inactivity, so it was unclear whether the 
product was degrading over time or if the reaction was simply not working.  The reaction 
conditions that were used most often began by stirring NaH (0.003 g, 0.137 mmol, 2 eq) with 
diethyl acetamidomalonate (0.015 g, 0.103 mmol, 1.5 eq) for 5 minutes in DMF (1 mL) in a 
flame-dried vial.  5 (0.023 g, 0.069 mmol, 1 eq) was dissolved in DMF (1 mL) and added to the 
reaction and the reaction vessel was wrapped in foil (16 h, 60 ˚C).  These conditions were 
attempted four times, but 6 was never produced.  Under these conditions, the reaction should 
occur by nucleophilic attack of the malonate derivative on the electrophilic bromine-bearing 
carbon.  A carbanion is readily formed by the abstraction of a proton from diethyl 
acetamidomalonate by the hydride ion, but its nucleophilicity is mitigated by steric hindrance.  
The electrophile is a primary carbon, but the presence of the bulky phenyl ring at the alpha 
position further impedes the progress of the reaction.  Consequently, based on literature 
precedence
20
, the reaction was attempted under microwave irradiation.  Instead of using NaH to 
abstract a proton from the malonic ester, Cs2CO3 was used to address safety issues that could 
arise from heating NaH to such high temperatures.  Acetonitrile was used as the solvent instead 
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of DMF, since it can tolerate large amounts of microwave energy.  This allowed the reaction to 
be heated to 130 ˚C, well above the conditions that were previously attempted.  This reaction was 
irradiated at this temperature for 10 minutes, providing a yield of 80%.  The success of these 
conditions is likely due to the increased input of energy that allowed the substitution reaction to 
overcome steric hindrance and the high-energy transition state. 
The conversion of 6 to 1 occurred under microwave irradiation in 6M HCl.  Compound 6 
had limited solubility in HCl, but as the deprotection of the malonic ester progressed, the more 
water soluble compound, 1 was produced.  This led to the solvation of some of the product, 
revealing the interior of the insoluble granules of starting material.  1 was still not particularly 
soluble, but the reaction was determined to have run to completion by NMR spectroscopic 
analysis.  1 could not  be purified by column chromatography since the amino acid backbone 
would bind quite strongly to the polar silica gel.  Another notable result is the lack of 
stereoselectivity in the deprotection; the reaction presumably results in a racemic mixture of the 
(D) and (L) diastereomers.  Only (L) amino acids can be translated by ribosomes, which implies 
that only about half of the quantity of 1 produced can be incorporated into proteins. 
 
Incorporation of the Synthesized Unnatural Amino Acid 
With the synthesized amino acid in hand, the next step involved the incorporation of the 
UAA into a protein.  GFP was used in this study as a model system to determine whether or not 
the UAA was incorporated into the protein.  A successful translation involving the UAA would 
lead to a functional fluorescent protein product, whereas in the absence of the UAA, GFP would 
be expressed at much lower levels or not at all.  This is due to the fact that the UAA is introduced 
in relatively high concentrations, and the pEVOL vector that is used to transform the bacteria 
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contains genes that encode the tRNA with the UAG  anticodon as well as two copies of the aaRS 
that charge the UAA to the exogenous tRNA.  In the absence of the UAA, bacterial release 
factors will bind to the stop codon on a more frequent basis, terminating translation of GFP. 
Typically, for each unnatural amino acid incorporated, an aaRS must be evolved that 
recognizes the UAA and charges the corresponding tRNA.  However, due to the tedious nature 
of aaRS selections, we first attempted to exploit the inherent promiscuity of previously evolved 
aaRSs.  Identifying an aaRS that could aminoacylate 1 to the orthogonal tRNA suppressor 
required the analysis of several candidates, since each aaRS in the laboratory was evolved to 
incorporate a few structurally similar UAAs.  The UAA 1 contains several different substituents 
that taken singularly have a previously evolved aaRS, such as pPrF, so an array of aaRSs was 
assessed.  Other aaRSs were selected for other properties, such as their incorporations of large 
aryl substituents like BipyA (2,2-bipyridylalanine).  BipyA, Ac32, and pPrF showed modest 
increases in fluorescence in samples supplemented with 1 (Fig. 18).  Other aaRSs had stronger 
fluorescence in wells lacking 1, indicating that the UAA is not incorporated with those 
synthetases, and that it may be toxic.  The toxicity might kill the cells at a rate such that GFP is 
more likely to be expressed by the incidental incorporation of natural amino acids to the UAG 
site in the control cells.  The wells containing 1 that had a stronger fluorescent signal than the 
respective -UAA control indicate that the UAA is being successfully incorporated.  Ultimately, 
BipyA showed to be the most efficacious aaRS based on results from PAGE analysis. 
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 1 2 3 4 5 6 7 8 9 10 11 12 
A ONBY +   ONBY -     pPrF +   pPrF -         
B                         
C Ac32 +   Ac32 -     Bipy +   Bipy -         
D                         
E pAzoF +   pAzoF -     Ambrx +   Ambrx -         
F                         
G CN3265 +   CN3265 -                   
H                         
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 14575   17615     20723   17004         
B                         
C 18559   17923     17537   14212         
D                         
E 14567   15385     17903   17978         
F                         
G 28455   38655                   
H                         
 
Figure 18:  Table and graphical depiction of fluorescent intensities of different aaRSs 
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Different GFP genes were used that replaced wild type codons with nonsense codons at 
residue sites 3, 133, and 151 to find the optimal site for conjugation.  The UAG codon in GFP3 is 
near the C terminus residue, 133 is in one of the loops that extends out from the barrel, and 151 
is on the barrel itself.  These sites are used because they are not the in the fluorophore, but are 
important in the maintenance or creation of it.  GFP 3 is a useful model, because no part of the 
protein is expressed in the absence of UAA.  GFP 133 and 151 both contain the nonsense codon 
downstream of the fluorophore, but if translation is terminated at those sites, the fluorophore 
cannot be formed.  The formation of the fluorophore is necessarily kept to the interior of the 
protein away from the aqueous environment.  Each of the three mutant sites is surface exposed, 
though the local environment differs between the three.  Testing the efficacy of the photoinitiated 
cycloaddition by the ortho-substituted nitro group can be assessed in the 133 and 151 variants, 
but not GFP3.  This is simply due to the fact that the reaction cleaves the peptide in two, and one 
of the products of this process in GFP3 would be a PAGE-undetectable tripeptide.  Incorporation 
of 1 to each of these sites should theoretically expose the alkyne to click reaction conditions.   
 
Optimization of Click Conjugation 
Initial work involved the click between 6 and NaN3, outside of the context of a protein in 
the presence of CuSO4 and sodium ascorbate.  Based on the success of this reaction (determined 
by NMR spectroscopy), the conditions were translated to a protein system with the various GFP 
mutants containing UAA 1.  Unfortunately, these results were somewhat inconclusive.  Instead 
of clicking with NaN3, the protein (30 μL) was clicked with N3PEG (1 μL, 5kD), a polymer of 
known weight that can be analyzed via PAGE.  Other changes in conditions included the use of 
TCEP (4 µL, 2mM) and TBTA (1 µL, 5 mM).  Proteins have more steric hindrance that may 
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lead to difficulty in setting up the geometry needed for the click reaction to proceed.  
Furthermore, Cu(I) catalyzes the formation of reactive oxygen species, which are reactive to 
proteins and may cause complications.
21
  Moreover, the protein was clicked with a 5kD PEG-
azide, resulting in a difference in size that is within the range of error of low percentage PAGE 
when a slightly uneven interface is present between the stacking and resolving layers of the gel.  
Consequently, more analyses must be performed to determine the success of this reaction in a 
protein context. 
 
Photocleavage of the Unnatural Amino Acid 
The capacity of the ortho-nitrobenzyl group of UAA 1 to undergo photoinitiated cleavage 
has been observed at various points throughout the synthesis.  The reactive nitro group was 
installed in the second reaction (3), and from that point onward, the photoreaction product was 
readily observed on TLC plates as a brown-yellow spot after irradiation with 365 nm light for 30 
seconds.  Unfortunately, the reaction has not been observed in GFP thus far.  UV light not only 
interacts with the nitro group of the UAA, but it can also cause other undesired ionizing effects 
on the protein and lead to numerous undesired side products.  When the protein containing 1 was 
irradiated with 365 nm light for 10 minutes and analyzed by PAGE, there were no distinct bands 
that indicated the peptide had successfully undergone this reaction.  We would expect for two 
distinct lighter bands to be present, each representing one of the two portions of the cleaved 
protein. 
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Synthesis of Other Unnatural Amino Acids 
Synthesis of pPrF 
 The propargylation of protected tyrosine by propargyl bromide to yield 8 proceeded by 
the same mechanism as the reaction with vanillin.  The yield was slightly lower for this reaction 
than the propargylation of vanillin (70% vs 77%).  The slight difference could be a result of 
using a different source of propargyl bromide as well as wet DMF. 
 The hydrolysis of the methyl ester (8) to a carboxylic acid (9) by 1M NaOH and dioxanes 
resulted in a low yield, likely because of the middling polarity of the product and its subsequent 
loss to the aqueous layer in the extraction.  This could be remedied by performing multiple 
extractions of smaller volume each time and using saturated brine. 
 
Synthesis of a Malonate-Derived Unnatural Amino Acid 
 The commercially available starting material for this UAA (BocNH(Phe4-I)) is not 
protected at the carboxylic acid, so it was esterified to prevent side reactions in future steps.  This 
was achieved by deprotonating the acid with NaHCO3, a weak base.  The carboxylate reacted 
with CH3I via a nucleophilic substitution reaction.  The reaction took two days of stirring at 60 
˚C to run to completion, possibly a result of dilute conditions.  This substitution reaction is 
concentration-dependent, since the nucleophile and the electrophile must directly interact with 
each other, which could contribute to the slow rate at which the reaction proceeds.  The protected 
phenylalanine derivative is then reacted with diethyl malonate to displace the para-iodide 
through nucleophilic aromatic substitution.  Cs2CO3 abstracts the acidic hydrogen of diethyl 
malonate, generating a resonance-stabilized carbanion.  This nucleophilic carbanion reacts with 
the carbon bonded to the iodide.  This is not an SN2 reaction, because the nucleophile would have 
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to add from inside the benzene ring to achieve the correct geometry to generate a Meisenheimer 
complex.  Instead, the malonic ester adds to the iodide carbon, forming a negatively charged 
species.  The iodide ion is a good leaving group, so it dissociates from the ring, leaving behind 
the desired product.  The product of this reaction was not recovered.  The transition state of this 
reaction is quite high, as it is difficult for the sterically hindered nucleophile to add to the 
electron-rich benzene ring.  Furthermore, the equilibrium of this reaction is probably somewhat 
equivalent between the dissociation of iodide and malonate, making it difficult to drive to 
completion. 
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Conclusion 
 Several syntheses of UAAs were attempted, two of which were completed.  The 
syntheses that were unable to be completed will require future efforts and modifications to the 
reaction conditions.  The formation of the malonate-derived UAA proceeds by nucleophilic 
aromatic substitution with a hindered nucleophile, so the use of microwave irradiation is a 
potential candidate to help facilitate the reaction.  The use of microwave irradiation in the 
reaction of 5 to 6 proved to be instrumental, which had analogous issues under thermal 
conditions.  The synthesis of UAAs with propyl and butyl linkers to propargyl groups have been 
shown to be successful (Maza, McKenna, unpublished), but the reaction with dibromoethane 
may be yielding the elimination product instead of the substitution product.  Changes to the 
conditions should divert the reaction from the elimination route. 
The UAA pPrF has been used as a known substrate for the aaRS by the same name as a 
control against other UAAs that are candidates for aminoacylation by that synthetase.  It has also 
been incorporated into proteins by other members of the lab and subjected to click reactions and 
Glaser-Hay coupling. 
UAA 1 has been shown to be incorporated into proteins, but successful click reactions 
and photocleavage reactions have not been observed.  Recent developments in the laboratory 
have indicated that effective click conditions involving proteins have been determined, however, 
so there is promise that this reaction can be observed soon.  The photoreaction was performed by 
irradiating the mutant GFP for 10 minutes with UV light, which may have been too harsh of 
conditions.  Decreased exposure time to irradiation will be used to determine the optimal 
duration of radiation that will lead to the peptidyl cleavage. 
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Future Directions 
 One of the overarching goals to the development of UAA technologies is the ability to 
treat diseases.  The incorporation of UAA 1 into an antibody and conjugation of a cytotoxic 
agent through a click reaction (Fig. 19) could be useful in the treatment of human diseases, 
including cancers.  Antibodies are immune proteins that have two variable regions that are highly 
discriminatory and bind tightly to a specific substrate (Fig. 20).
1
  Cancer cells express unique 
surface markers for which antibodies can be developed against.  Conjugation to canonical amino 
acids on an antibody is not ideal since there is little control over how many residues will react 
and the location of those residues.
13
  If those reactive side chains are in the variable region, the 
function of the antibody is negated and no binding can occur.  The site-specific incorporation of 
a UAA to the non-variable region of an antibody provides a way to overcome these two 
obstacles.  With a single side chain alkyne in this region, one azide-containing drug can be 
conjugated without disrupting antibody function and the immunoconjugate can selectively bind 
cancer cells when introduced to the patient.  The presence of the ortho-nitrobenzyl group 
provides temporal control for the release of the UAA and delivery of the drug once the antibody 
has been endocytosed by cells (Fig. 19). 
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Figure 19: General scheme for the incorporation of 1 into a protein, conjugation, and UV-controlled release 
 
 
Figure 20: Illustration of an antibody 
https://www.pblassaysci.com/sites/pblassaysci/files/images/Antibody%20structure.jpg 
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